As of 2025-06-15, the Intrinsic Value of Dr Agarwal's Eye Hospital Ltd (526783.BO) is 4,367.15 INR. This 526783.BO valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 4,408.00 INR, the upside of Dr Agarwal's Eye Hospital Ltd is -0.90%.
The range of the Intrinsic Value is 3,777.66 - 5,139.60 INR
Based on its market price of 4,408.00 INR and our intrinsic valuation, Dr Agarwal's Eye Hospital Ltd (526783.BO) is overvalued by 0.90%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 3,777.66 - 5,139.60 | 4,367.15 | -0.9% |
| DCF (Growth 10y) | 7,155.51 - 9,735.03 | 8,272.98 | 87.7% |
| DCF (EBITDA 5y) | 11,447.09 - 23,660.24 | 18,126.12 | 311.2% |
| DCF (EBITDA 10y) | 14,042.38 - 28,758.36 | 21,659.83 | 391.4% |
| Fair Value | 2,906.93 - 2,906.93 | 2,906.93 | -34.05% |
| P/E | 2,099.96 - 15,240.52 | 6,370.83 | 44.5% |
| EV/EBITDA | 1,415.44 - 14,866.18 | 6,744.14 | 53.0% |
| EPV | 185.32 - 346.73 | 266.03 | -94.0% |
| DDM - Stable | 566.98 - 930.47 | 748.73 | -83.0% |
| DDM - Multi | 4,062.92 - 5,320.94 | 4,614.68 | 4.7% |
| Market Cap (mil) | 20,717.60 |
| Beta | 0.59 |
| Outstanding shares (mil) | 4.70 |
| Enterprise Value (mil) | 23,927.50 |
| Market risk premium | 8.31% |
| Cost of Equity | 13.80% |
| Cost of Debt | 5.73% |
| WACC | 12.71% |